Crossmark

Potential of plasma metagenomic next-generation sequencing to guide antibiotic therapy in acute necrotizing pancreatitis with early fever: a prospective multicenter cohort study

Crossref DOI link: https://doi.org/10.1186/s13756-026-01822-8

Published Online: 2026-09-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hong, Xiaoyue

Shen, Dingcheng

Lin, Chiayen

Cao, Xintong

Sun, Zefang

Liu, Baiqi

Guo, Rong

Liu, Zhiyong

Luo, Tao

Yu, Yi

Yang, Ming

Feng, Bin

Zhang, Wenqian

Huang, Gengwen
License Information

Text and Data Mining valid from 2026-09-10

Version of Record valid from 2026-09-10
More Information

Article History

Received: 10 May 2026

Accepted: 2 September 2026

First Online: 10 September 2026

Declarations

Ethical approval and consent to participate: The study protocol was reviewed and approved by the ethics committee of Xiangya Hospital, Central South University (reference: 202304286, approval date: April 24, 2023) and registered by the ethics committees of all the participating hospitals, and was conducted under the Declaration of Helsinki. Written informed consent was obtained from all patients or their representative for the study participation.

Consent for publication: Not applicable.

Research registration: Name of the registry: Chinese Clinical Trial Registry (ChiCTR). Unique Identifying number or registration ID: ChiCTR2300071292. Hyperlink to your specific registration (must be publicly accessible and will be checked): https://www.chictr.org.cn/.

Competing interests: The authors declare no competing interests.

Document is current

Any future updates will be listed below